Chemiluminescence Immunoassay (CLIA) Analyzers Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025

Published on : Apr-2020 | List of Tables : 36 | List of Figures : 76 | No. of Pages : 170 | Report Code : FACT4734MR | Format :

Laboratory Automation, Rising COVID-19 cases to Bring about Positive Growth in the CLIA Market

The number of tests incorporating Chemiluminescence Immunoassay Analyzers (CLIA) techniques is forecast to aggrandize, attributed to technological advances in disease diagnosis, rise in demand for preventive diagnosis and treatment monitoring. Consequently, demand for high throughput facilities are also augmenting. Moreover, large-scale laboratories are taking advantage of quality and service constraints faced by small and mid-volume laboratories to capture a larger share of the market using CLIA techniques.

International conglomerates operating in the clinical labs segment are expanding their base through mergers and acquisitions in emerging markets. The consolidation among laboratories is resulting in rising test volumes, which is leading to rising adoption of complete laboratory automation and integration. On the back of these trends, the global CLIA market is anticipated to grow positively at a CAGR of 6.4% during the forecast period (2020-2025). It is expected to reach US$ 7.6 Bn by 2025-end.

The COVID-19 pandemic is anticipated to provide further impetus to the global chemiluminescence immunoassays market. Several market players and healthcare agencies are investing in developing diagnostic tests based on CLIA technique to ascertain growth inhibition approaches to the novel coronavirus using a range of techniques

Innovative Disease Diagnostics, Integrated Immunoassay Platforms Provide Technological Boost in the CLIA Market

Continuous research and development activities are leveraging the global CLIA market. Constant innovation in disease diagnostics is a key reason. In October 2017, Shenzen Mindray Biomedical Electronics Co., Ltd became the first China-based manufacturer to receive the list A CE marking for infectious disease tests, including HIV and HBV CLA test kits.

Introduction of next-generation integrated immunoassays is a major technological advancement. In October 2017, Abbott announced the FDA 510(k) clearance for Alinity ci-series instruments for immunoassay diagnostics. Earlier, the company also announced approval of its Atellica Solutions for clinical chemistry and immunoassays.

Fully-automated Analyzers Demonstrate Expanding Trends, Reagents to Remain Dominant

Fully-automated analyzers are prophesied to grow impressively at a CAGR of 6.7% throughout the forecast period. This is attributed to increasing number of integrated systems offerings by key market players providing standardized tests. Fully-automated analyzers are poised to reach US$ 1.08 Bn by the end of 2025.

At the same time, the reagents segment is forecast to continue dominating the global CLIA market. This is attributed to its lower cost, shorter test time and increasing demand from emerging markets. The reagents segment is anticipated to capture almost three-fourth of the overall CLIA market, reaching a value of US$ 5.7 Bn by the end of 2025.

global  chemiluminescence immunoassays  market 01

Get access to our exclusive insights on the chemiluminescence immunoassays analyzers market by asking an analyst here

Endocrine Disorders to Capture Maximum Share of the CLIA Market

The endocrine disorders segment is anticipated to find widespread application of chemiluminescence immunoassays. The segment shall capture nearly half of the overall CLIA market, expanding at a CAGR of 6.9%, as majority of the market players are involved in this segment.

Trailing behind is the oncology segment, capturing more than one-tenth of the global CLIA market. The segment is anticipated to expand at a CAGR of 6.6%. Rising prevalence of cancer and its early diagnosis shall drive market growth. A well-established distribution network of key market players is also poised to leverage the oncology segment.

North America to Remain Kingpin, Asia-Pacific to Grow Robustly

North America shall retain its dominance over the global CLIA market. Rise in demand for faster and specific diagnosis to support rapid decision-making is boosting the demand for multiplexed and automated CLIA immunoassay analyzers. Anticipated CAGR for the North American CLIA market is pegged at 6.1%, capturing a market share of nearly two-fifth.

Asia-Pacific is set to record dexterous growth in the future. Gradual adoption of novel products comprising CLIA technologies, increased healthcare expenditure, rising competition among market players and national and international accreditations to establish new laboratories are key growth drivers. Anticipated CAGR for the Asia-Pacific region is a healthy 7.6%, capturing a quarter of the global CLIA market.

global  chemiluminescence immunoassays  market 02

To know more about the chemiluminescence immunoassay analyzers market, request for a report sample here

Expansion of Test Offering, Innovations in Integrated Platforms Pave Way for Competitive Edge

The global CLIA market is highly consolidated, dominated by four key market players. These are: F. Hoffmann La Roche Ltd., Abbott Laboratories, Siemens Healthineers and Beckman Coulter, Inc. Expansion of test offerings in innovative disease diagnosis areas and innovations in integrated immunoassay platforms are important strategies of these players.

For example, in December 2017, Beckman Coulter, Inc. received clearance from the FDA for its Access AMH immunoassay which uses recombinant human antigens for determining anti-Mullerian hormone (AMH) levels. At present, Beckman Coulter, Inc. offers various immunoassay systems under the clinical products segment. These include the Access 2 Immunoassay System and the UniCel Dxl 600 Access Immunoassay System.

Similarly, F. Hoffmann La Roche Ltd. offers clinical chemistry and immunology analyzers and assays for small, medium and large-scale laboratories. Its products include the cobas4000 analyzer series, the cobas6000 analyzer series and the cobas8000 modular analyzer series.

COVID-19 Market Insights:

The COVID-19 pandemic is anticipated to leverage market prospects for the chemiluminescence immunoassays market. This is owing to its potential application in eradicating the disease. Studies are underway for developing a peptide-based magnetic chemiluminescence enzyme immunoassay for serological diagnosis of the coronavirus disease. This is a significant development because this is the second diagnostic test after real-time RT-PCR, which is the only available laboratory test to confirm possible cases of infection.

Beckman Coulter, a leading chemiluminescence immunoassay manufacturer, is providing the indirect measles immunoglobulin (IgM) serology and Immunoglobulin G (IgG) serology assays to determine whether a patient has developed an immune reaction to the SARS-COV-2 virus. This understanding would ultimately assist medical practitioners to identify those who would require a vaccine once available. Likewise, Roche AG has accelerated its study of Actemra, a potential drug capable of providing relief to severe COVID-19 pneumonia patients. The company confirmed the initiation of a randomized, double-blind, placebo-controlled Phase III clinical trial, in collaboration with the Biomedical Advanced Research and Development Authority (BARDA). The study, codenamed COVACTA, will evaluate the safety and efficacy of intravenous Actemra ®/RoActemra ® for adult patients suffering from acute COVID-19 induced pneumonia.

Analyst’s Viewpoint:

“Key manufacturers are increasingly investing in CLIA-based techniques for providing testing kits to its clients. The COVID-19 pandemic has further heightened prospects for the CLIA market. Development of a peptide-based magnetic chemiluminescence enzyme immunoassay for serological diagnosis is under way to that effect. Overall, the global CLIA market is poised to enjoy a positive growth trajectory.”

Global CLIA Market: Report Scope:

The global chemiluminescence immunoassays market study by Fact.MR offers a 5-year forecast between 2020 and 2025. The report includes important drivers, restraints, opportunities and threats to the expansion of the CLIA market. Detailed analysis based on different segments has been provided. Market segmentation has been done on the basis of application, product and end-user. A value-based analysis of each segment has been given in the report, along with various sub-segments.

In-depth regional analysis of the market has also been incorporated. The regional analysis has fragmented the world into five geographies: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA). Each region has been analyzed on the basis of the segmentations highlighted above. A separate section on the competition landscape has been included as well. Detailed profiles of major market players, their expansion strategies and future outlook have been elaborated upon in this section.

Global Chemiluminescence Immunoassays (CLIA) Market- Scope of the Report

The recent study by Fact.MR on global Chemiluminescence Immunoassays (CLIA) market offers a 5-year forecast between 2020 and 2025. The study analyzes crucial trends that are currently determining the growth of the global chemiluminescence immunoassays (CLIA) market. This report explicates on vital dynamics such as the drivers, restraints and opportunities for key market players along with key stakeholders as well as emerging players associated with the development of chemiluminescence immunoassays (CLIA). The study also provides dynamics that are responsible for influencing the future status of the global chemiluminescence immunoassays (CLIA) market over the forecast period.

A detailed assessment of the global chemiluminescence immunoassays (CLIA) market value chain analysis, business execution, and supply chain analysis across the regional markets has been covered in the report. A list of prominent companies operating in the global chemiluminescence immunoassays (CLIA) market along with their product portfolio enhances the reliability of this comprehensive research study.

Global Chemiluminescence Immunoassays (CLIA) Market: Report Summary

The study offers a comprehensive analysis on diverse features including production capacities, demand, product developments, revenue generation and sales in the global chemiluminescence immunoassays (CLIA) market across the globe.

A comprehensive estimate on the global chemiluminescence immunoassays (CLIA) market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of global chemiluminescence immunoassays (CLIA) devices during the forecast period. Price point comparison by region with global average price is also considered in the study.

Global Chemiluminescence Immunoassays (CLIA) Market Segmentation

Fact.MR has studied the global chemiluminescence immunoassays (CLIA) market with detailed segmentation on the basis of application, product, end-user and key regions.

Application

Product

End-User

Key Regions

Endocrine Disorders

Analyzers:

Fully-automated

Semi-automated

Hospitals

North America

Oncology

Reagents:

Luminophore Markers

Enzymatic Markers

Clinical Laboratories

Europe

Infectious Diseases

Consumables

Pharmaceutical & Biological Industries

Asia Pacific

Hepatitis and Retrovirus

 

Others

Latin America

Cardiovascular Disorders

 

 

Middle East & Africa

Allergy

 

 

 

Autoimmunity

 

 

 

Drug Discovery & Development

 

 

 

Others

 

 

 

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”

Global Chemiluminescence Immunoassays (CLIA) market: Analysis on Market Size Evaluation

The global chemiluminescence immunoassays (CLIA) market has been analyzed for each market segment, in terms of value (US$ Mn).

Market estimates at global and regional levels for global chemiluminescence immunoassays (CLIA) is available in terms of “US$ Mn” for value, along with market attractiveness evaluation in the report.  A Y-o-Y growth contrast on prominent glaucoma therapeutic segments, along with market attractiveness evaluation has been incorporated in the report.

Global Chemiluminescence Immunoassays (CLIA) Market: Inspected Assessment on Regional Segments

Key sections have been elaborated in the global chemiluminescence immunoassays (CLIA) market report, which have helped to deliver projection on the regional markets. These chapters include the regional macros (economic and business environment outlook), which are expected to have a momentous influence on the growth of global chemiluminescence immunoassays (CLIA) market during the forecast period.

Country-specific valuation on demand for global chemiluminescence immunoassays (CLIA) has been offered for each regional market, along with the market scope estimate and forecast, price index, and impact analysis of dynamics of prominence in regions and countries. Detailed breakup in terms of value for emerging countries has also been included in the report.

Global Chemiluminescence Immunoassays (CLIA) Market: In-Depth Analysis on Competitive Landscape

The report sheds light on the leading manufacturers of global chemiluminescence immunoassays (CLIA) devices along with their detailed profiles. Essential and up-to-date data information related to the market performers, who are principally engaged in the production of global chemiluminescence immunoassays (CLIA) devices, has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits the report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which includes essentials such as product portfolio, key strategies along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through the matrix for all the prominent players thus providing the readers with actionable insights, which helps in thoughtfully presenting market status, and predicting the competition level in global chemiluminescence immunoassays (CLIA) market. Prominent manufacturers with established market presence in global chemiluminescence immunoassays (CLIA) market are F. Hoffmann- La Roche Ltd., Abbott, Siemens Healthineers (Siemens AG), Danaher (Beckman Coulter, Inc.), DiaSorin S.p.A, New Industries Biomedical Engineering Co. Ltd and Randox Laboratories, Ltd to name a few.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market 

4. Market Overview

    4.1. Introduction

        4.1.1. Product Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

            4.3.1.1. Ultrasensitive method with wider dynamic range of tests

            4.3.1.2. Growing demand for international accreditations and result comparability using high throughput automated immunoassays

        4.3.2. Restraints

            4.3.2.1. Availability of alternative diagnostic test at relatively lower cost

            4.3.2.2. Fragmented consumables market affecting profit margin

        4.3.3. Opportunity

    4.4. Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Analysis and Forecasts, 2020–2025

        4.4.1. Market Revenue Projections (US$ Mn)

    4.5. Market Outlook

    4.6. Disease Prevalence & Incidence Rate globally with key countries

    4.7. Technological Advancements

    4.8. Top 3 players operating in the market space

    4.9. Healthcare Industry Overview

5. Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Analysis and Forecasts, By Product Type 

    5.1. Introduction & Definition

    5.2. Key Findings / Developments

    5.3. Market Value Forecast By Product Type, 2020–2025

        5.3.1. Analyzers

            5.3.1.1. Automated

            5.3.1.2. Semi-automated

        5.3.2. Reagents

            5.3.2.1. Luminophore Markers

            5.3.2.2. Enzymatic Markers

        5.3.3. Consumables

    5.4. Market Attractiveness By Product Type 

6. Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Analysis and Forecasts, By Application 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast By Application, 2020–2025

        6.3.1. Endocrine Disorders

        6.3.2. Oncology

        6.3.3. Infectious Diseases

        6.3.4. Hepatitis and Retrovirus

        6.3.5. Cardiovascular Disorders

        6.3.6. Allergy

        6.3.7. Autoimmunity

        6.3.8. Drug Discovery and Development

        6.3.9. Others

    6.4. Market Attractiveness By Application 

7. Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Analysis and Forecasts, By End-user 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast By End-user, 2020–2025

        7.3.1. Hospitals

        7.3.2. Clinical Laboratories

        7.3.3. Pharmaceutical & Biotechnology Industries

        7.3.4. Others 

    7.4. Market Attractiveness By End-user 

8. Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Analysis and Forecasts, By Region

    8.1. Key Findings

    8.2. Market Value Forecast By Region

        8.2.1. North America 

        8.2.2. Europe 

        8.2.3. Asia Pacific 

        8.2.4. Latin America 

        8.2.5. Middle East & Africa 

    8.3. Market Attractiveness By Country/Region

9. North America Chemiluminescence Immunoassay (CLIA) Analyzers Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast By Product Type, 2020–2025

        9.2.1. Analyzers

            9.2.1.1. Automated

            9.2.1.2. Semi-automated

        9.2.2. Reagents

            9.2.2.1. Luminophore Markers

            9.2.2.2. Enzymatic Markers

        9.2.3. Consumables

    9.3. Market Value Forecast By Application, 2020–2025

        9.3.1. Endocrine Disorders

        9.3.2. Oncology

        9.3.3. Infectious Diseases

        9.3.4. Hepatitis and Retrovirus

        9.3.5. Cardiovascular Disorders

        9.3.6. Allergy

        9.3.7. Autoimmunity

        9.3.8. Drug Discovery and Development

        9.3.9. Others

    9.4. Market Value Forecast By End-user, 2020–2025

        9.4.1. Hospitals

        9.4.2. Clinical Laboratories

        9.4.3. Pharmaceutical & Biotechnology Industries

        9.4.4. Others 

    9.5. Market Value Forecast By Country, 2020–2025

        9.5.1. U.S.

        9.5.2. Canada

    9.6. Market Attractiveness Analysis 

        9.6.1. By Product Type 

        9.6.2. By Application 

        9.6.3. By End-user 

        9.6.4. By Country

10. Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast By Product Type, 2020–2025

        10.2.1. Analyzers

            10.2.1.1. Automated

            10.2.1.2. Semi-automated

        10.2.2. Reagents

            10.2.2.1. Luminophore Markers

            10.2.2.2. Enzymatic Markers

        10.2.3. Consumables

    10.3. Market Value Forecast By Application, 2020–2025

        10.3.1. Endocrine Disorders

        10.3.2. Oncology

        10.3.3. Infectious Diseases

        10.3.4. Hepatitis and Retrovirus

        10.3.5. Cardiovascular Disorders

        10.3.6. Allergy

        10.3.7. Autoimmunity

        10.3.8. Drug Discovery and Development

        10.3.9. Others

    10.4. Market Value Forecast By End-user, 2020–2025

        10.4.1. Hospitals

        10.4.2. Clinical Laboratories

        10.4.3. Pharmaceutical & Biotechnology Industries

        10.4.4. Others 

    10.5. Market Value Forecast By Country/Sub-region, 2020–2025

        10.5.1. Germany

        10.5.2. U.K.

        10.5.3. France

        10.5.4. Spain

        10.5.5. Italy

        10.5.6. Rest of Europe

    10.6. Market Attractiveness Analysis 

        10.6.1. By Product Type 

        10.6.2. By Application 

        10.6.3. By End-user 

        10.6.4. By Country/Sub-region

11. Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast By Product Type, 2020–2025

        11.2.1. Analyzers

            11.2.1.1. Automated

            11.2.1.2. Semi-automated

        11.2.2. Reagents

            11.2.2.1. Luminophore Markers

            11.2.2.2. Enzymatic Markers

        11.2.3. Consumables

    11.3. Market Value Forecast By Application, 2020–2025

        11.3.1. Endocrine Disorders

        11.3.2. Oncology

        11.3.3. Infectious Diseases

        11.3.4. Hepatitis and Retrovirus

        11.3.5. Cardiovascular Disorders

        11.3.6. Allergy

        11.3.7. Autoimmunity

        11.3.8. Drug Discovery and Development

        11.3.9. Others

    11.4. Market Value Forecast By End-user, 2020–2025

        11.4.1. Hospitals

        11.4.2. Clinical Laboratories

        11.4.3. Pharmaceutical & Biotechnology Industries

        11.4.4. Others 

    11.5. Market Value Forecast By Country/Sub-region, 2020–2025

        11.5.1. China

        11.5.2. Japan

        11.5.3. India

        11.5.4. Australia & New Zealand

        11.5.5. Rest of Asia Pacific

    11.6. Market Attractiveness Analysis 

        11.6.1. By Product Type 

        11.6.2. By Application 

        11.6.3. By End-user 

        11.6.4. By Country/Sub-region

12. Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast By Product Type, 2020–2025

        12.2.1. Analyzers

            12.2.1.1. Automated

            12.2.1.2. Semi-automated

        12.2.2. Reagents

            12.2.2.1. Luminophore Markers

            12.2.2.2. Enzymatic Markers

        12.2.3. Consumables

    12.3. Market Value Forecast By Application, 2020–2025

        12.3.1. Endocrine Disorders

        12.3.2. Oncology

        12.3.3. Infectious Diseases

        12.3.4. Hepatitis and Retrovirus

        12.3.5. Cardiovascular Disorders

        12.3.6. Allergy

        12.3.7. Autoimmunity

        12.3.8. Drug Discovery and Development

        12.3.9. Others

    12.4. Market Value Forecast By End-user, 2020–2025

        12.4.1. Hospitals

        12.4.2. Clinical Laboratories

        12.4.3. Pharmaceutical & Biotechnology Industries

        12.4.4. Others 

    12.5. Market Value Forecast By Country/Sub-region, 2020–2025

        12.5.1. Brazil

        12.5.2. Mexico

        12.5.3. Rest of Latin America

    12.6. Market Attractiveness Analysis 

        12.6.1. By Product Type 

        12.6.2. By Application 

        12.6.3. By End-user 

        12.6.4. By Country/Sub-region

13. Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast By Product Type, 2020–2025

        13.2.1. Analyzers

            13.2.1.1. Automated

            13.2.1.2. Semi-automated

        13.2.2. Reagents

            13.2.2.1. Luminophore Markers

            13.2.2.2. Enzymatic Markers

        13.2.3. Consumables

    13.3. Market Value Forecast By Application, 2020–2025

        13.3.1. Endocrine Disorders

        13.3.2. Oncology

        13.3.3. Infectious Diseases

        13.3.4. Hepatitis and Retrovirus

        13.3.5. Cardiovascular Disorders

        13.3.6. Allergy

        13.3.7. Autoimmunity

        13.3.8. Drug Discovery and Development

        13.3.9. Others

    13.4. Market Value Forecast By End-user, 2020–2025

        13.4.1. Hospitals

        13.4.2. Clinical Laboratories

        13.4.3. Pharmaceutical & Biotechnology Industries

        13.4.4. Others 

    13.5. Market Value Forecast By Country/Sub-region, 2020–2025

        13.5.1. GCC Countries

        13.5.2. South Africa

        13.5.3. Israel

        13.5.4. Rest of Middle East & Africa

    13.6. Market Attractiveness Analysis 

        13.6.1. By Product Type 

        13.6.2. By Application 

        13.6.3. By End-user 

        13.6.4. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player – Competition Matrix (By Tier and Size of companies)

    14.2. Market Share Analysis By Company (2018)

    14.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)

        14.3.1. Abbott

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strengths)

            14.3.1.2. Financial Overview

            14.3.1.3. Product Portfolio

            14.3.1.4. SWOT Analysis

            14.3.1.5. Strategic Overview

        14.3.2. F. Hoffmann-La Roche Ltd 

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strengths)

            14.3.2.2. Financial Overview

            14.3.2.3. Product Portfolio

            14.3.2.4. SWOT Analysis

            14.3.2.5. Strategic Overview 

        14.3.3. Siemens Healthcare GmbH (Siemens AG) 

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strengths)

            14.3.3.2. Financial Overview

            14.3.3.3. Product Portfolio

            14.3.3.4. SWOT Analysis

            14.3.3.5. Strategic Overview

        14.3.4. Danaher (Beckman Coulter, Inc.) 

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strengths)

            14.3.4.2. Financial Overview

            14.3.4.3. Product Portfolio

            14.3.4.4. SWOT Analysis

            14.3.4.5. Strategic Overview

        14.3.5. DiaSorin S.p.A. 

            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strengths)

            14.3.5.2. Financial Overview

            14.3.5.3. Product Portfolio

            14.3.5.4. SWOT Analysis

            14.3.5.5. Strategic Overview

        14.3.6. Ortho Clinical Diagnostics (Part of Carlyle Group) 

            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strengths)

            14.3.6.2. Financial Overview

            14.3.6.3. Product Portfolio

            14.3.6.4. SWOT Analysis

            14.3.6.5. Strategic Overview

        14.3.7. Shenzhen New Industries Biomedical Engineering Co., Ltd.

            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strengths)

            14.3.7.2. Financial Overview

            14.3.7.3. Product Portfolio

            14.3.7.4. SWOT Analysis

            14.3.7.5. Strategic Overview

        14.3.8. Sysmex Corporation 

            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strengths)

            14.3.8.2. Financial Overview

            14.3.8.3. Product Portfolio

            14.3.8.4. SWOT Analysis

            14.3.8.5. Strategic Overview

        14.3.9. Randox Laboratories Ltd. 

            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strengths)

            14.3.9.2. Financial Overview

            14.3.9.3. Product Portfolio

            14.3.9.4. SWOT Analysis

            14.3.9.5. Strategic Overview

        14.3.10. Tosoh Corporation

            14.3.10.1. Company Overview (HQ, Business Segments, Employee Strengths)

            14.3.10.2. Financial Overview

            14.3.10.3. Product Portfolio

            14.3.10.4. SWOT Analysis

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Chemiluminescence Immunoassay (CLIA) Analyzers Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025